Ixazomib for Treatment of Chronic Graft vs. Host Disease

Trial Profile

Ixazomib for Treatment of Chronic Graft vs. Host Disease

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Sep 2017

At a glance

  • Drugs Ixazomib (Primary)
  • Indications Graft-versus-host disease
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 12 Sep 2017 Status changed from recruiting to active, no longer recruiting.
    • 11 Jan 2016 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
    • 06 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top